Patents by Inventor Eva Haidweger

Eva Haidweger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lyophilized recombinant VWF formulations
    Patent number: 12653867
    Abstract: The present invention provides long-term stable pharmaceutical formulations of lyophilized recombinant von-Willebrand Factor (rVWF) and methods for making and administering said formulations.
    Type: Grant
    Filed: October 29, 2021
    Date of Patent: June 16, 2026
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Kurt Schnecker, Eva Haidweger, Peter Turecek
  • LYOPHILIZED RECOMBINANT VWF FORMULATIONS
    Publication number: 20220257723
    Abstract: The present invention provides long-term stable pharmaceutical formulations of lyophilized recombinant von-Willebrand Factor (rVWF) and methods for making and administering said formulations.
    Type: Application
    Filed: October 29, 2021
    Publication date: August 18, 2022
    Inventors: Kurt Schnecker, Eva Haidweger, Peter Turecek
  • Lyophilized recombinant VWF formulations
    Patent number: 11197916
    Abstract: Long-term stable pharmaceutical formulations of lyophilized recombinant von-Willebrand Factor (rVWF) and methods for making and administering said formulations are described.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: December 14, 2021
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Kurt Schnecker, Eva Haidweger, Peter Turecek
  • Lyophilized recombinant VWF formulations
    Patent number: 11191813
    Abstract: Long-term stable pharmaceutical formulations of lyophilized recombinant von-Willebrand Factor (rVWF) and methods for making and administering said formulations are described.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: December 7, 2021
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Kurt Schnecker, Eva Haidweger, Peter Turecek
  • LYOPHILIZED RECOMBINANT VWF FORMULATIONS
    Publication number: 20210315979
    Abstract: The present invention provides long-term stable pharmaceutical formulations of lyophilized recombinant von-Willebrand Factor (rVWF) and methods for making and administering said formulations.
    Type: Application
    Filed: January 25, 2019
    Publication date: October 14, 2021
    Inventors: Kurt Schnecker, Eva Haidweger, Peter Turecek
  • LYOPHILIZED RECOMBINANT VWF FORMULATIONS
    Publication number: 20210308227
    Abstract: The present invention provides long-term stable pharmaceutical formulations of lyophilized recombinant von-Willebrand Factor (rVWF) and methods for making and administering said formulations.
    Type: Application
    Filed: January 25, 2019
    Publication date: October 7, 2021
    Inventors: Kurt Schnecker, Eva Haidweger, Peter Turecek
  • LYOPHILIZED RECOMBINANT VWF FORMULATIONS
    Publication number: 20190142908
    Abstract: The present invention provides long-term stable pharmaceutical formulations of lyophilized recombinant von-Willebrand Factor (rVWF) and methods for making and administering said formulations.
    Type: Application
    Filed: January 25, 2019
    Publication date: May 16, 2019
    Inventors: Kurt Schnecker, Eva Haidweger, Peter Turecek
  • LYOPHILIZED RECOMBINANT VWF FORMULATIONS
    Publication number: 20190142907
    Abstract: The present invention provides long-term stable pharmaceutical formulations of lyophilized recombinant von-Willebrand Factor (rVWF) and methods for making and administering said formulations.
    Type: Application
    Filed: January 25, 2019
    Publication date: May 16, 2019
    Inventors: Kurt Schnecker, Eva Haidweger, Peter Turecek
  • Lyophilized recombinant VWF formulations
    Patent number: 10232022
    Abstract: Long-term stable pharmaceutical formulations of lyophilized recombinant von-Willebrand Factor (rVWF) and methods for making and administering said formulations are described.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: March 19, 2019
    Assignees: Baxalta Incorporated, Baxalta GmbH
    Inventors: Kurt Schnecker, Eva Haidweger, Peter Turecek
  • LYOPHILIZED RECOMBINANT VWF FORMULATIONS
    Publication number: 20160129090
    Abstract: The present invention provides long-term stable pharmaceutical formulations of lyophilized recombinant von-Willebrand Factor (rVWF) and methods for making and administering said formulations.
    Type: Application
    Filed: November 12, 2015
    Publication date: May 12, 2016
    Inventors: Kurt Schnecker, Eva Haidweger, Peter Turecek
  • LYOPHILIZED RECOMBINANT VWF FORMULATIONS
    Publication number: 20100099603
    Abstract: The present invention provides long-term stable pharmaceutical formulations of lyophilized recombinant von-Willebrand Factor (rVWF) and methods for making and administering said formulations.
    Type: Application
    Filed: October 21, 2009
    Publication date: April 22, 2010
    Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A.
    Inventors: Kurt Schnecker, Eva Haidweger, Peter Turecek